Skip to content
Dawson James Logo
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • MANAGING PARTNERS
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
  • Open an Account
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • MANAGING PARTNERS
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
  • Open an Account
Loading...
Report – DelMar Pharmaceuticalsnerdadmin2020-11-23T08:59:22-05:00

DelMar Pharmaceuticals, Inc.

Latest Publication

Update 09/09/2020
Update 07/30/2020
Update 06/24/2020
Update 06/23/2020
Update 06/10/2020
Update 06/04/2020
Update 05/13/2020
Update 05/05/2020
Update 03/05/2020
Update 02/14/2020
Update 12/02/2019
Update 9/18/2019
Update 8/27/2019
Update 7/31/2019
Update 7/24/2019
Update 7/15/2019
Update 7/11/2019
Update 3/1/2018
Update 8/8/2017
Initiation 06/06/17

  • Research Philosophy
  • Reports
  • Sector Research
  • Appearances


“To view Dawson James’ Business Continuity Plan amidst the COVID-19 crisis please click here for more information.”

Please note our Corporate address has changed as of October 12, 2020.

Dawson James Securities Inc.
Member FINRA/SIPC
101 N. Federal Highway Suite 600 Boca Raton, Florida 33432
Privacy Pledge | Contact Us | Terms & Conditions | FINRA | SIPC | FINRA BrokerCheck | Fees | Disclosures | Rule 606 Reports | Client Login

“To view Dawson James’ Business Continuity Plan amidst the COVID-19 crisis please click here for more information.”

Go to Top